Ellington Management Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ellington Management Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,900	Closed	-$137K	–	851
2019 Q2	$137K	Buy	+15,900	New	+$142K	0.02%	528
2017 Q4	–	Sell	-15,700	Closed	-$221K	–	865
2017 Q3	$221K	Buy	+15,700	New	+$142K	0.04%	494
2017 Q2	–	Sell	-28,500	Closed	-$185K	–	960
2017 Q1	$185K	Buy	+28,500	New	+$159K	0.01%	602
2014 Q4	–	Sell	-63,200	Closed	-$514K	–	650
2014 Q3	$514K	Buy	+63,200	New	+$495K	0.35%	43

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellington Management Group's SPPI Position: Q3 2019 in Review

Ellington Management Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 15,900 shares — an estimated $137K sold.

Ellington Management Group first reported a position in SPPI in Q3 2014 and held it in 4 quarters. The position peaked at $514K in Q3 2014. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Ellington Management Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Ellington Management Group sold 15,900 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $137K.
Ellington Management Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 4 quarters.
Ellington Management Group's Spectrum Pharmaceuticals Inc position peaked at $514K in Q3 2014.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Ellington Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.